微信小陈
微信小章| 产品名称： | Klebsiella pneumoniae subsp. pneumoniae (Schroeter) Trevisan |
|---|---|
| 商品货号： | TS170072 |
| Application： | Control of experimental infections Respiratory research |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Antigenic Properties： | Serotype 2 |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 3: Nutrient agar or nutrient broth |
| Growth Conditions： | Temperature: 37°C Atmosphere: Aerobic |
| Name of Depositor： | IA Woudenberg-Bakker |
| Chain of Custody： | ATCC |
| References： | Bakker-Woudenberg IA, et al. Relevance of serum protein binding of cefoxitin and cefazolin to their activities against Klebsiella pneumoniae pneumonia in rats. Antimicrob. Agents Chemother. 28: 654-659, 1985. PubMed: 3911879 Roosendaal R, et al. Continuous versus intermittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic rats. Antimicrob. Agents Chemother. 30: 403-408, 1986. PubMed: 3535664 Roosendaal R, et al. Therapeutic efficacy of continuous versus intermittent administration of ceftazidime in an experimental Klebsiella pneumoniae pneumonia in rats. J. Infect. Dis. 152: 373-378, 1985. PubMed: 3897395 Roosendaal R, et al. Comparative activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in experimental pneumonia in leukopenic rats. Antimicrob. Agents Chemother. 31: 1809-1815, 1987. PubMed: 3324962 |